How cool would it be to stop cancer dead in its tracks using a vaccine that would work regardless of cancer type? It turns out that humanity is already thinking along those lines, and it’s looking to introduce a type of “universal cancer vaccine” that would be able to trigger the human’s body built-in defenses to kill cancerous cells.
Specifically, researchers at the Johannes Gutenberg University in Mainz, Germany, have initiated a limited safety human trial, after experiments on mice showed impressive results.
Don’t miss: This might be the most exciting and unexpected Apple announcement at WWDC 2016.
Read more
Comments are closed.